Abbott India, Pfizer, L&T Infotech: 11 stocks that may enter F&O segment

The eligibility of stock inclusion in the derivatives / F&O segment is based on the criteria laid down by market regulator Sebi.

Pharma companies such as Abbott India, Pfizer, and Ipca Lab are among the eleven companies that, according to ICICI Securities, are likely to be included in the futures & options (F&O) segment.

In the last F&O inclusion, NSE had announced the introduction of SBI Life Insurance in April 2020. Prior to that, in February 2020, three new stocks were added to the F&O segment after a gap of almost two years, the report adds.

The eligibility of stock inclusion in the derivatives / F&O segment is based on the criteria laid down by market regulator Securities and Exchange Board of